Table 1 Baseline characteristics of the study population
| Â | non-frequent PDAP | frequent PDAP | t/x | p |
|---|---|---|---|---|
Gender | Â | Â | 2.204 | NS |
Male | 85 (64.39%) | 41 (53.94%) | Â | Â |
Female | 47 (35.61%) | 35 (46.05%) | Â | Â |
Age (year) | 51.8 ± 13.34 | 50.37 ± 13.82 | 0.737 | NS |
Etiology of ESRD | Â | Â | Â | |
Chronic glomerulonephritis | 61 (46.21%) | 39 (51.32%) | 0.503 | NS |
Diabetic nephropathy | 24 (18.18%) | 22 (28.95%) | 3.245 | NS |
Hypertensive nephropathy | 29 (21.97%) | 8 (10.53%) | 4.319 | 0.038 |
Other | 18 (13.64%) | 7 (9.21%) | 1.352 | NS |
Comorbidities | Â | Â | Â | Â |
Hypertension (n, %) | 106 (80.30%) | 56 (73.68%) | 2.43 | NS |
Diabetes mellitus (n, %) | 29 (21.97%) | 30 (39.47%) | 7.273 | 0.007 |
Causal factors [cases (%)] | Â | Â | 2.769 | NS |
mishandling | 64 | 28 | Â | Â |
Substandard environment | 12 | 13 | Â | Â |
Intestinal infections | 46 | 29 | Â | Â |
Exit Tunnel Infection | 10 | 6 | Â | Â |
Causative organisms | Â | Â | Â | |
Gram-positive (n, %) | Â | Â | Â | |
Staphylococci | 38 (28.79%) | 12 (15.79%) | 4.463 | 0.035 |
Streptococcus | 11 (8.33%) | 8 (10.53%) | 0.279 | NS |
Enterococcus spp | 3 (2.27%) | 1 (1.32%) | 0.234 | NS |
Other | 4 (3.03%) | 4 (5.26%) | 0.65 | NS |
Gram-negative (n, %) | Â | Â | Â | |
Pseudomonas aeruginosa | 3 (2.27%) | 2 (2.63%) | 0.026 | NS |
Escherichia coli | 26 (19.70%) | 14 (18.42%) | 0.051 | NS |
Klebsiella spp | 3 (2.27%) | 2 (5.26%) | 0.026 | NS |
Other | 4 (3.03%) | 4 (5.26%) | 0.65 | NS |
Culture negative (n, %) | 40 (30.30%) | 29 (38.16%) | 1.324 | NS |
Outcome | Â | Â | Â | Â |
Effective Treatment | 102 (77.27%) | 42 (55.26%) | 10.968 | 0.001 |
Ineffective extubation | 20 (15.15%) | 21 (27.63%) | 4.747 | 0.029 |
Peritonitis-related death | 10 (7.58%) | 13 (17.11%) | 4.453 | 0.035 |
Follow-up duration | 55 (30.5–81.5) | 67 (50.5–79) | -1.87 | NS |